Association of METTL14 expression with prognosis and immunotherapy in breast cancer

Key Points

• METTL14 expression is linked to breast cancer prognosis, indicating its clinical relevance.
• A predictive value associated with METTL14 suggests that it could serve as a biomarker for treatment outcomes.
• Observational analysis indicates that METTL14 may be a promising target in immunotherapy strategies for breast cancer.
• Further investigation is necessary to validate METTL14's role as a therapeutic target due to its potential implications in treatment.

Abstract